Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:687-698
Published online before print August 10, 2009, doi: 10.1161/CIRCULATIONAHA.109.856070
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/8/687    most recent
CIRCULATIONAHA.109.856070v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Oh, J.
Right arrow Articles by Bernal-Mizrachi, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, J.
Right arrow Articles by Bernal-Mizrachi, C.
Related Collections
Right arrow Lipids
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Type 2 diabetes
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

(Circulation. 2009;120:687-698.)
© 2009 American Heart Association, Inc.


Vascular Medicine

1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus

Jisu Oh, BS*; Sherry Weng, MD*; Shaili K. Felton, MD; Sweety Bhandare, MD; Amy Riek, MD; Boyd Butler, PhD; Brandon M. Proctor, PhD; Marvin Petty, BS; Zhouji Chen, MD, PhD; Kenneth B. Schechtman, PhD; Leon Bernal-Mizrachi, MD; Carlos Bernal-Mizrachi, MD

From Endocrinology, Metabolism, and Lipid Research, Department of Medicine (J.O., S.W., S.K.F., A.R., M.P., C.B.-M.), Division of Nephrology, Department of Pediatrics (S.B.), Department of Cell Biology and Physiology (B.B., C.B.-M.), Cardiovascular Division, Department of Medicine (B.M.P., K.B.S.), Geriatrics and Division of Nutritional Science, Department of Medicine (Z.C.), and Division of Biostatistics (K.B.S.), Washington University, St Louis, Mo, and Hematology/Oncology, Winship Cancer Institute, Emory University (L.B.-M.), Atlanta, Ga.

Correspondence to Carlos Bernal-Mizrachi, Washington University School of Medicine, Campus Box 8127, 660 S Euclid Ave, St. Louis, MO 63110. E-mail cbernal{at}dom.wustl.edu

Received February 3, 2009; accepted June 15, 2009.

Background— Cardiovascular disease is the leading cause of death among those with diabetes mellitus. Vitamin D deficiency is associated with an increased risk of cardiovascular disease in this population. To determine the mechanism by which vitamin D deficiency mediates accelerated cardiovascular disease in patients with diabetes mellitus, we investigated the effects of active vitamin D on macrophage cholesterol deposition.

Methods and Results— We obtained macrophages from 76 obese, diabetic, hypertensive patients with vitamin D deficiency (25-hydroxyvitamin D <80 nmol/L; group A) and 4 control groups: obese, diabetic, hypertensive patients with normal vitamin D (group B; n=15); obese, nondiabetic, hypertensive patients with vitamin D deficiency (group C; n=25); and nonobese, nondiabetic, nonhypertensive patients with vitamin D deficiency (group D; n=10) or sufficiency (group E; n=10). Macrophages from the same patients in all groups were cultured in vitamin D—deficient or 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] –supplemented media and exposed to modified low-density lipoprotein cholesterol. 1,25(OH)2D3 suppressed foam cell formation by reducing acetylated or oxidized low-density lipoprotein cholesterol uptake in diabetic subjects only. Conversely, deletion of the vitamin D receptor in macrophages from diabetic patients accelerated foam cell formation induced by modified LDL. 1,25(OH)2D3 downregulation of c-Jun N-terminal kinase activation reduced peroxisome proliferated–activated receptor-{gamma} expression, suppressed CD36 expression, and prevented oxidized low-density lipoprotein–derived cholesterol uptake. In addition, 1,25(OH)2D3 suppression of macrophage endoplasmic reticulum stress improved insulin signaling, downregulated SR-A1 expression, and prevented oxidized and acetylated low-density lipoprotein–derived cholesterol uptake.

Conclusion— These results identify reduced vitamin D receptor signaling as a potential mechanism underlying increased foam cell formation and accelerated cardiovascular disease in diabetic subjects.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 647-648. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ. Res.Home page
I. Tabas, A. Tall, and D. Accili
The Impact of Macrophage Insulin Resistance on Advanced Atherosclerotic Plaque Progression
Circ. Res., January 8, 2010; 106(1): 58 - 67.
[Abstract] [Full Text] [PDF]